Related Experiment Video
Updated: Jun 4, 2025
07:21
Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
37.2K
ClC-5 knockout mitigates angiotensin II-induced hypertension and endothelial dysfunction
Lu Sun1, Min Gao2, Gui-Yong Yang3
1Department of Pharmacology, Cardiac & Cerebral Vascular Research Center, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China; Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China.
Life Sciences
|December 31, 2024
Summary
ClC-5 channel knockout in mice improves nitric oxide production, reducing hypertension and endothelial dysfunction. This occurs by regulating the WNK1/RhoA/Akt/eNOS pathway, offering potential therapeutic targets.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Renal Physiology
Background:
- Nitric oxide (NO) deficiency contributes to endothelial dysfunction and hypertension.
- The role of ClC-5 chloride channels in vascular endothelium regulation is not fully understood.
Purpose of the Study:
- To investigate the function of ClC-5 chloride channels in the vascular endothelium.
- To determine the impact of ClC-5 on endothelial function and blood pressure regulation.
Main Methods:
- Utilized mice with global or endothelium-specific Clcn5 gene knockout.
- Assessed blood pressure and endothelial function in response to Angiotensin II.
- Investigated the involvement of the Akt/eNOS and WNK1/RhoA signaling pathways.
Main Results:
- ClC-5 knockout mitigated Angiotensin II-induced hypertension and endothelial dysfunction.
- Knockout reversed impaired NO production by activating the Akt/eNOS pathway.
- ClC-5 and WNK1 regulate NO production via the WNK1/RhoA/Akt/eNOS signaling cascade.
Conclusions:
- ClC-5 knockout ameliorates hypertension and endothelial dysfunction by enhancing NO production.
- The WNK1/RhoA/Akt/eNOS pathway is a key mechanism regulated by ClC-5.
- Findings suggest ClC-5 as a potential therapeutic target for endothelial dysfunction-related diseases.
More Related Videos
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
472
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
472
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
01:25Antihypertensive Drugs: Direct Renin Inhibitors
484
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
484
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
579
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
579
01:17Antihypertensive Drugs: Action of β1 Blockers
306
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
306
01:33Hormonal Regulation
32.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.9K